Print

APT Starts Human Trials Of Aerosolized Hydroxychloroquine For Asthma 
10/19/2005 5:10:06 PM

APT Pharmaceuticals is beginning clinical studies of aerosolized hydroxychloroquine (AHCQ) for treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), rhinitis and severe acute respiratory syndrome (SARS).
//-->